{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T20:07:40Z","timestamp":1785614860098,"version":"3.56.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,8,27]],"date-time":"2005-08-27T00:00:00Z","timestamp":1125100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00431-005-1719-7","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T08:57:52Z","timestamp":1125046672000},"page":"735-740","source":"Crossref","is-referenced-by-count":6,"title":["Vaccine strategies of meningococcal disease: results of a 10-year population-based study"],"prefix":"10.1007","volume":"164","author":[{"given":"Ariane","family":"Biebl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Bechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Luckner-Hornischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fr\u00fchwirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Heuberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Offner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Simma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,8,27]]},"reference":[{"key":"1719_CR1","first-page":"1","volume":"49","author":"Advisory","year":"2000","unstructured":"Advisory Committee on Immunization Practices (ACIP) (2000) Prevention and control of meningococcal disease. MMWR 49: 1\u201310","journal-title":"MMWR"},{"key":"1719_CR2","first-page":"1","volume":"49","author":"Advisory","year":"2000","unstructured":"Advisory Committee on Immunization Practices (ACIP) (2000) Preventing pneumococcal disease among infants and young children. MMWR 49: 1\u201335","journal-title":"MMWR"},{"key":"1719_CR3","unstructured":"Campell H, Ramsay M, Gungabisson U (2002) Impact of meningococcal C conjugate vaccination programme in England. Surveillance Report from the Public Health Laboratory Service (PHLS)"},{"key":"1719_CR4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s15010-003-3121-6","volume":"31","author":"Cardenosa","year":"2003","unstructured":"Cardenosa N, Dominguez A, Martinez A (2003) Meningococcal disease in Catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine. Infection 31: 392\u2013397","journal-title":"Infection"},{"key":"1719_CR5","first-page":"261","volume":"9","author":"Communicable","year":"1999","unstructured":"Communicable Disease Surveillance Centre(1999) Vaccination programme for group C meningococcal infection is launched. Commun Dis Rep Wkly 9: 261\u2013264","journal-title":"Commun Dis Rep Wkly"},{"key":"1719_CR6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1023\/A:1026100321871","volume":"18","author":"De","year":"2003","unstructured":"De Schrijver K, Maes I (2003) An outbreak of serogroup C meningococcal disease in the province of Antwerp (Belgium) in 2001\u20132002. Eur J Epidemiol 18: 1073\u20131077","journal-title":"Eur J Epidemiol"},{"key":"1719_CR7","first-page":"1562","volume":"146","author":"De","year":"2002","unstructured":"De Vries M, Dankert J, Ruijs H (2002) Universal vaccination against group C meningococci and pneumococci: advice from the Health Council of the Netherlands. Ned Tijdschr Geneeskd 146: 1562\u20131563","journal-title":"Ned Tijdschr Geneeskd"},{"key":"1719_CR8","unstructured":"Heuberger S, Pekard-Amenitsch S (2002) Yearly report of meningococcal disease in Austria. National Reference Centre for Meningococcal Disease. AGES (Agentur f\u00fcr Gesundheit und Ern\u00e4hrungssicherheit)"},{"key":"1719_CR9","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","volume":"359","author":"Maiden","year":"2002","unstructured":"Maiden MC, Stuart JM (2002) Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359: 1829\u20131831","journal-title":"Lancet"},{"key":"1719_CR10","first-page":"ACS","volume":"27","author":"National","year":"2002","unstructured":"National Advisory Committee on Immunization (NACI) (2002) Statement on recommended use of meningococcal vaccines. Can Commun Dis Rep 27: ACS-6","journal-title":"Can Commun Dis Rep"},{"key":"1719_CR11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00006454-200004000-00012","volume":"19","author":"Pastor","year":"2000","unstructured":"Pastor P, Medley FB, Murphy TV (2000) Meningococcal disease in Dallas County, Texas: results of a 6-year population-based study. Pediatr Infect Dis J 19: 324\u2013328","journal-title":"Pediatr Infect Dis J"},{"key":"1719_CR12","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1086\/378743","volume":"37","author":"Patrick","year":"2003","unstructured":"Patrick DM, Champagne S, Goh SH (2003) Neisseria meningitidis carriage during an outbreak of serogroup C disease. Clin Infect Dis 37: 1183\u20131188","journal-title":"Clin Infect Dis"},{"key":"1719_CR13","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1016\/S0264-410X(03)00562-0","volume":"21","author":"Ruedin","year":"2003","unstructured":"Ruedin HJ, Ess S, Zimmermann HP, Szucs T (2003) Invasive meningococcal and pneumococcal disease in Switzerland: cost-utility analysis of different vaccine strategies. Vaccine 21: 4145\u20134152","journal-title":"Vaccine"},{"key":"1719_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1695-4033(01)78651-1","volume":"54","author":"Soult","year":"2001","unstructured":"Soult Rubio JA, Munoz SM, Lopez Castilla JD (2001) Meningococcal disease. New prevention strategies. An Esp Pediatr 54: 65\u201368","journal-title":"An Esp Pediatr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-005-1719-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-005-1719-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-005-1719-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T06:40:48Z","timestamp":1586414448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-005-1719-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,27]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["1719"],"URL":"https:\/\/doi.org\/10.1007\/s00431-005-1719-7","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,27]]}}}